HOUSE DOCKET, NO. 3835        FILED ON: 2/19/2021

HOUSE  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  No. 2361

 

The Commonwealth of Massachusetts

_________________

PRESENTED BY:

Elizabeth A. Malia

_________________

To the Honorable Senate and House of Representatives of the Commonwealth of Massachusetts in General
Court assembled:

The undersigned legislators and/or citizens respectfully petition for the adoption of the accompanying bill:

An Act to expand naloxone access.

_______________

PETITION OF:

 

Name:

District/Address:

Date Added:

Elizabeth A. Malia

11th Suffolk

2/16/2021

Jon Santiago

9th Suffolk

6/15/2021

Jack Patrick Lewis

7th Middlesex

12/16/2021


HOUSE DOCKET, NO. 3835        FILED ON: 2/19/2021

HOUSE  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  No. 2361

By Ms. Malia of Boston, a petition (accompanied by bill, House, No. 2361) of Elizabeth A. Malia for legislation to expand naloxone access.  Public Health.

 

The Commonwealth of Massachusetts

 

_______________

In the One Hundred and Ninety-Second General Court
(2021-2022)

_______________

 

An Act to expand naloxone access.

 

Be it enacted by the Senate and House of Representatives in General Court assembled, and by the authority of the same, as follows:
 

SECTION 1. Chapter 94C of the General Laws, as appearing in the 2018 Official edition, is hereby amended by inserting after section 18C the following new section:-

Section 18D. In the event that a practitioner issues a prescription for an opioid contained in Schedule II of section 3, the practitioner shall also issue a prescription for an opioid antagonist if one of the following conditions is present: (i) the patient is prescribed an opioid which individually or in aggregate with other medications is more than equal to 50 morphine milligram equivalents per day; (ii) the patient is prescribed any dose of an opioid when a benzodiazepine has been prescribed in the past 30 days or will be prescribed at the visit; or (iii) the patient has a prior history of opioid use disorder or overdose or has a history of substance use disorder.  If the practitioner does not co-prescribe an opioid antagonist at the time said prescription for an opioid is issued, the practitioner shall document in the patient’s medical record why co-prescription of an opioid antagonist was not appropriate for the patient.